Drugs / DTaP-IPV-Hep B-PRP-T Vaccine
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01177722 | Aug 2010 → Oct 2011 | diphtheria, hepatitis B virus infection, pertussis, poliomyelitis +1 | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
| Phase 3 | NCT00654901 | Mar 2008 → May 2009 | diphtheria, haemophilus infectious disease, hepatitis B virus infection, pertussis +2 | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DTaP-IPV-Hep B-PRP-T Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01177722 ↗ |
| Modality | Vaccine | “Combined Vaccine” NCT00654901 ↗ |
| Route | Intramuscular | “0.5 mL, Intramuscular” NCT00654901 ↗ |